Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02668666
Recruitment Status : Active, not recruiting
First Posted : January 29, 2016
Last Update Posted : July 29, 2020
Sponsor:
Collaborators:
Pfizer
Big Ten Cancer Research Consortium
Information provided by (Responsible Party):
Oana Danciu, MD, Big Ten Cancer Research Consortium

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : January 2022